Target DPI Specializes in low cost passive dry powder inhaler (DPI) solutions with a focus on consistent emitted dose and fine particle fraction, presenting a cost-effective option for partners seeking scalable inhalation devices.

Strategic Location Based in Cambridge, MA, a hub for biotech and medtech collaboration, offering proximity to potential partners, academic institutions, and contract manufacturers to accelerate development timelines.

Partnership Readiness Focus on development expertise to optimize proprietary devices for inhaled dose delivery positions Manta Devices as a potential R&D collaborator or outsourced engineering partner for device-enabled pharma clients.

Modest Scale Revenue under one million with a lean team suggests agility and low overhead, which can be attractive for small to mid-sized pharma or startup collaborations seeking flexible engagement models.

Tech and Cloud Utilizes mainstream tech stack (WordPress, Shopify, Google Cloud) indicating readiness for client-facing demonstrations, partner portals, and scalable web marketing to support business development and project proposals.